The groundbreaking approach of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – resulting in enhanced glucose management and possible weight reduction. … Read More